ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate (2018)
- Authors:
- Amôr, Nádia Ghinelli - Universidade de São Paulo (USP)
- Oliveira, Carine Ervolino de - Universidade de São Paulo (USP)
- Gasparoto, Thaís Helena - Universidade de São Paulo (USP)
- Vilas Boas, Vanessa Garcia - Universidade de São Paulo (USP)
- Perri, Graziela - Universidade de São Paulo (USP)
- Kaneno, Ramon
- Lara, Vanessa Soares
- Garlet, Gustavo Pompermaier
- Silva, João Santana da
- Martins, Gislaine Aparecida
- Hogaboam, Cory
- Cavassani, Karen Angelica
- Campanelli, Ana Paula
- Amôr, Nádia Ghinelli - Universidade de São Paulo (USP)
- USP affiliated authors: LARA, VANESSA SOARES - FOB ; GARLET, GUSTAVO POMPERMAIER - FOB ; SILVA, JOÃO SANTANA DA - FMRP ; CAMPANELLI, ANA PAULA - FOB
- Unidades: FOB; FMRP
- DOI: 10.18632/oncotarget.30894
- Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS; CAMUNDONGOS; INTERLEUCINAS; CARCINÓGENOS QUÍMICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Oncotarget
- ISSN: 1949-2554
- Volume/Número/Paginação/Ano: v. 9, n. 56, p. 30894-30904, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AMÔR, Nádia Ghinelli et al. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget, v. 9, n. 56, p. 30894-30904, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.30894. Acesso em: 30 dez. 2025. -
APA
Amôr, N. G., Oliveira, C. E. de, Gasparoto, T. H., Vilas Boas, V. G., Perri, G., Kaneno, R., et al. (2018). ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget, 9( 56), 30894-30904. doi:10.18632/oncotarget.30894 -
NLM
Amôr NG, Oliveira CE de, Gasparoto TH, Vilas Boas VG, Perri G, Kaneno R, Lara VS, Garlet GP, Silva JS da, Martins GA, Hogaboam C, Cavassani KA, Campanelli AP. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate [Internet]. Oncotarget. 2018 ; 9( 56): 30894-30904.[citado 2025 dez. 30 ] Available from: https://doi.org/10.18632/oncotarget.30894 -
Vancouver
Amôr NG, Oliveira CE de, Gasparoto TH, Vilas Boas VG, Perri G, Kaneno R, Lara VS, Garlet GP, Silva JS da, Martins GA, Hogaboam C, Cavassani KA, Campanelli AP. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate [Internet]. Oncotarget. 2018 ; 9( 56): 30894-30904.[citado 2025 dez. 30 ] Available from: https://doi.org/10.18632/oncotarget.30894 - CCR5-dependent homing of T regulatory cells to the tumor microenvironment contributes to skin squamous cell carcinoma development
- Elastase and cytokines in actinic cheilitis and oral squamous cell carcinoma
- CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses
- CCR5 mediates pro-osteoclastic and osteoclastogenic leukocyte chemoattraction
- Patients with Lepromatous Leprosy are characterized by increased frequency of suppressive regulatory T cells in the blood and lesions
- Inflammatory mediators in murine squamous cell carcinoma
- Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression
- Distinct roles for genetic (MMP1-1607 and -519 SNPs) factors and periodontopathogens in the modulation of MMP-1 levels in healthy and diseased periodontal tissues
- The broad effects of the functional IL-10 promoter -592 polymorphism: modulation of IL-10, TIMP-3 and OPG expression and its association with periodontal disease outcome
- Evidence supporting a protective role for Th9 and Th22 cytokines in human and experimental periapical lesions
Informações sobre o DOI: 10.18632/oncotarget.30894 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
